Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter
YouTube

-9° Clear
- Broken Bow, NE (68822)
  Today
  
  Cloudy. A few flurries or snow showers possible. High 27F. Winds SSW at 15 to 25 mph..
  
  Tonight
  
  Evening clouds will give way to clearing. Low around 20F. Winds W at 10 to 15 mph.
  
  Updated: January 31, 2026 @ 1:52 am
- Full Forecast

Site search

Home
News
- Local News
Sports
Obituaries
Photos
Videos
e-Edition
Classifieds
Business Directory
Best of 2024

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by OKYO Pharma LTD

< Previous 1 2 3 Next >

OKYO Pharma Limited Regains Compliance with Nasdaq Listing Minimum Market Value Rule

August 29, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Limited Reports Annual Results for the Twelve Months Ended March 31, 2023

August 15, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Limited Announces Withdrawal of Public Offering

July 31, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Announces Proposed Public Offering of Ordinary Shares

July 28, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Limited Receives Nasdaq Deficiency Notice

July 28, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain (“NCP”) Following Announcement of Clinical Trial Agreement with Tufts Medical Center

July 28, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Announces Appointment of William A. Clementi as Chief Operating Officer

July 27, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Announces Randomized Segment Now Underway in Phase 2 Clinical Trial of Topical Ocular OK-101 for Dry Eye Disease

June 06, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Now Participating on the Webull Corporate Communications Service Platform

May 11, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Announces Presentations at the American Society of Cataract and Refractive Surgery (ASCRS 2023) in San Diego, CA, May 5-8, 2023

May 03, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Announces First-Patient First-Visit for Phase 2 Trial Evaluating Efficacy and Safety of OK-101 in Patients with Dry Eye Disease

May 02, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Announces Activation of First Clinical Trial Site in the U.S. for the Phase 2 Trial Evaluating OK-101 for the Treatment of Dry Eye Disease

April 25, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

Notice of General Meeting and Publication of Circular

April 05, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

Notice of Intention to Delist From The London Stock Exchange

April 04, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Today Announces Director Acquires Shares

March 30, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Today Announces Director Acquires Shares

March 29, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Announces PDMR Dealing

March 24, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Announces Phase 2 Trial of OK-101 Drug to Treat Dry Eye Disease is now listed on the ClinicalTrials.gov Public Website

March 16, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Limited announces U.S.$5.74 million Global Private Placement and investment by directors and members of senior management

March 14, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Limited Prices $5.3 Million Offering of ADSs

March 13, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Announces Custom Clearance of GMP Packaged OK-101 Drug to be Used in Phase 2 Clinical Trial for Treating Dry Eye Disease

February 28, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Announces Appointment of Dr. Jay S. Pepose to Its Scientific Advisory Board

February 23, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma to Present at the Second Annual GPCRs-Targeted Drug Discovery Summit in Boston, MA on February 21-23, 2023.

February 21, 2023

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Limited - Interim Results for the Six Months Ending 30 September 2022

December 30, 2022

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Announces U.S. FDA Clearance of IND Application for OK-101 for the Treatment of Dry Eye Disease

December 22, 2022

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO to Participate at Biotech Showcase

December 21, 2022

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Limited ("OKYO" or the "Company") - OKYO publicly files a registration statement with the SEC

December 06, 2022

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Limited - Change of Auditor

December 01, 2022

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Limited – PDMR dealing

November 24, 2022

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

OKYO Pharma Announces U.S. IND Filing on OK-101 for the Treatment of Dry Eye Disease

November 21, 2022

From OKYO Pharma LTD

Via GlobeNewswire

Tickers OKYO

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Business
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Pay Your Bill
Classifieds
Promote Your Event
Email Alerts
Place an Ad
Rack Locations
Search
Weather

custercountychief.com
305 South 10th Avenue
Broken Bow, NE 68822
Phone: 308-872-2471
Email: publisher@custercountychief.com

Facebook
Twitter
YouTube

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Consent Preferences

Broken Bow, NE (68822)

Today

Tonight

Articles published by OKYO Pharma LTD

Sections

Services

Follow Us